Evidence map›Paper›PMID 27756911›Full record

ArticleThe Journal of antibiotics2017

Antiviral effect of theaflavins against caliciviruses.

Mai Ohba, Tomoichiro Oka, Takayuki Ando, Saori Arahata, Asaka Ikegaya, Hirotaka Takagi, Naohisa Ogo, Chelsea Zhu, Kazuhiro Owada, Fumihiko Kawamori and 3 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in The Journal of antibiotics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Investigation of the AzoreanAntioxidants (Basel, Switzerland) · 2022
    Article
  3. Effects of theaflavin-gallatePhytomedicine plus : international journal of phytotherapy and phytopharmacology · 2022
    Article
  4. Review
  5. Article
  6. Article
  7. Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review.Phytomedicine : international journal of phytotherapy and phytopharmacology · 2021
    Review
  8. Review
  9. Article
  10. Norovirus antivirals: Where are we now?Medicinal research reviews · 2019
    Review
  11. Synthesis of Theaflavins and Their Functions.Molecules (Basel, Switzerland) · 2018
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Mai OhbaCenter for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
Tomoichiro OkaDepartment of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
Takayuki AndoCenter for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
Saori ArahataDepartment of Microbiology, Shizuoka Institute of Environment and Hygiene, Shizuoka, Japan.
Asaka IkegayaDepartment of Microbiology, Shizuoka Institute of Environment and Hygiene, Shizuoka, Japan.
Hirotaka TakagiDivision of Biosafety Control and Research, National Institute of Infectious Diseases, Tokyo, Japan.
Naohisa OgoCenter for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
Chelsea ZhuDepartment of Veterinary Preventive Medicine, Food Animal Health Research Program, Ohio Agricultural Research and Development Center, College of Veterinary Medicine, The Ohio State University, Wooster, OH, USA.
Kazuhiro OwadaDepartment of Pharmaceutical and Food Science, Shizuoka Institute of Environment and Hygiene, Shizuoka, Japan.
Fumihiko KawamoriDepartment of Microbiology, Shizuoka Institute of Environment and Hygiene, Shizuoka, Japan.
Qiuhong WangDepartment of Veterinary Preventive Medicine, Food Animal Health Research Program, Ohio Agricultural Research and Development Center, College of Veterinary Medicine, The Ohio State University, Wooster, OH, USA.
Linda J SaifDepartment of Veterinary Preventive Medicine, Food Animal Health Research Program, Ohio Agricultural Research and Development Center, College of Veterinary Medicine, The Ohio State University, Wooster, OH, USA.
Akira AsaiCenter for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
University of Shizuoka · JPThe Ohio State University · USNational Institute of Infectious Diseases · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Caliciviruses are contagious pathogens of humans and various animals. They are the most common cause of viral gastroenteritis in humans, and can cause lethal diseases in domestic animals such as cats, rabbits and immunocompromised mice. In this study, we conducted cytopathic effect-based screening of 2080 selected compounds from our in-house library to find antiviral compounds against three culturable caliciviruses: feline calicivirus, murine norovirus (MNV) and porcine sapovirus (PoSaV). We identified active six compounds, of which two compounds, both related to theaflavins, showed broad antiviral activities against all three caliciviruses; three compounds (abamectin, a mixture of avermectin B1a and B1b; avermectin B1a; and (-)-epigallocatechin gallate hydrate) were effective against PoSaV only; and a heterocyclic carboxamide derivative (BFTC) specifically inhibited MNV infectivity in cell cultures. Further studies of the antiviral mechanism and structure-activity relationship of theaflavins suggested the following: (1) theaflavins worked before the viral entry step; (2) the effect of theaflavins was time- and concentration-dependent; and (3) the hydroxyl groups of the benzocycloheptenone ring were probably important for the anti-calicivirus activity of theaflavins. Theaflavins could be used for the calicivirus research, and as potential disinfectants and antiviral reagents to prevent and control calicivirus infections in animals and humans.

Indexed as

AnimalsAntiviral AgentsBiflavonoidsCaliciviridaeCaliciviridae InfectionsCalicivirus, FelineCatechinCatsCytopathogenic Effect, ViralDrug Evaluation, PreclinicalFlavinsHumansIvermectinMiceNorovirusProtein Structure, QuaternaryabamectinAntiviral AgentsavermectinBiflavonoidsCatechinepigallocatechin gallateFlavinsIvermectintheaflavin

Identifiers

PMID27756911
OpenAlexW2532914623

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.